By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TRACON Pharmaceuticals, Inc. 

4510 Executive Drive
Suite 330
San Diego  California  92121  U.S.A.
Phone: 858-550-0780 Fax: 858-550-0786


SEARCH JOBS


Industry
Biotechnology






Company News
TRACON Pharmaceuticals, Inc. (TCON) Announces Positive Phase 1b Results For TRC105 In Combination With Inlyta (Axitinib) At The ASCO 2015 Genitourinary Cancers Symposium 3/2/2015 7:06:30 AM
TRACON Pharmaceuticals, Inc. (TCON) Appoints Stephen Worland To Its Board Of Directors 2/27/2015 7:41:54 AM
TRACON Pharmaceuticals, Inc. (TCON) Announces Upcoming Presentation Of Results From A Clinical Trial Of TRC105 In Patients With Renal Cell Carcinoma At The American Society of Clinical Oncology 2015 Genitourinary Cancers Symposium 2/20/2015 7:29:06 AM
TRACON Pharmaceuticals, Inc. Announces Pricing Of Initial Public Offering 1/30/2015 7:35:47 AM
TRACON Pharmaceuticals, Inc. Announces Results From A Clinical Trial Of TRC105 In Patients With Hepatocellular Carcinoma To Be Presented At The American Society of Clinical Oncology 2015 Gastrointestinal Cancers Symposium 1/9/2015 10:25:14 AM
San Diego Biotech TRACON Pharmaceuticals, Inc. (TCON) Files for $58 Million IPO 12/30/2014 6:15:24 AM
TRACON Pharmaceuticals, Inc. Initiates Randomized Phase 2 Clinical Trial Of TRC105 In Patients With Renal Cell Carcinoma 12/1/2014 10:33:41 AM
TRACON Pharmaceuticals, Inc. Announces Results From Clinical Trials Of TRC105 In Patients With Ovarian Cancer To Be Presented At The 2014 Annual Meeting Of The European Society For Medical Oncology 9/25/2014 7:36:33 AM
San Diego's TRACON Pharmaceuticals, Inc. Reels In $27 Million 9/22/2014 6:01:42 AM
TRACON Pharmaceuticals, Inc. Initiates Phase 2 Clinical Trial Of TRC105 In Patients With Soft Tissue Sarcoma 9/4/2014 10:15:57 AM
1234
//-->